Abstract
Paget disease of bone (PDB) is the second most common metabolic bone disease. It is a chronic disease with a mono- or polyostotic appearance that is characterized by an increased bone turnover. The orthopedic surgeon is often confronted with such symptoms and complications as bone pain, skeletal deformities, and pathologic fractures caused by the “out-of-balance bone remodeling process”. Careful evaluation of the clinical and radiographic findings is necessary to determine whether treatment of PDB is indicated. The mode of action of effective pharmacological treatments consists of reducing the increase in osteoclast-mediated bone resorption that characterizes the disease. Bisphosphonates are the compounds of choice for PDB therapy; these are readily available and have received approval. Patients with PDB are at increased risk for surgical complications, such as blood loss and heterotopic bone formation, if operative treatment is necessary. However, advances in surgical techniques and accompanying medical treatment could potentially improve the overall outcome of these patients. To achieve that goal, careful perioperative interdisciplinary management and monitoring are essential.
Similar content being viewed by others
References
Paget J. On a form of chronic inflammation of bone. Medico Chir Trans (London) 1877;60:37–64.
Morissette J, Laurin N, Brown JP. Sequestosome 1: mutation frequencies, haplotypes, and phenotypes in familial Paget’s disease of bone. J Bone Miner Res 2006;21:P38–44.
Watts GD, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, Pestronk A, Whyte MP, Kimonis VE. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 2004;36:377–381.
Mills BG, Singer FR. Nuclear inclusions in Paget’s disease of bone. Science 1976;194:201–202.
Beneton M, Harris S, Kanis J. Paramyxovirus-like inclusions in two cases of pyknodysostosis. Bone 1987;8:211–217.
Mills BG, Yabe H, Singer FR. Osteoclasts in human osteopetrosis contain viral-nucleocapsid-like nuclear inclusions. J Bone Miner Res 1988;3:101–106.
Gennari L, Merlotti D, Martini G, Nuti R. Paget’s disease of bone in Italy. J Bone Miner Res 2006;21:P14–21.
Eekhoff ME, van der Klift M, Kroon HM, Cooper C, Hofman A, Pols HA, Papapoulos SE. Paget’s disease of bone in The Netherlands: a population-based radiological and biochemical survey — the Rotterdam Study. J Bone Miner Res 2004;19:566–570.
Seitz S, Priemel M, Zustin J, Beil FT, Semler J, Minne H, Schinke T, Amling M. Paget’s disease of bone — histologic analysis of 754 patients. J Bone Miner Res 2008 [Epub ahead of print].
Selby PL. Guidelines for the diagnosis andmanagement of Paget’s disease: a UK perspective. J Bone Miner Res 2006;21:P92–3.
Mankin HJ, Hornicek FJ. Paget’s sarcoma: a historical and outcome review. Clin Orthop Relat Res 2005;438:97–102.
Katzer A, Beecken WD, Meenen NM, Jungbluth KH, Delling G. Pathologic humeral fracture in secondary osteosarcoma of the humerus: a rare complication of osteodystrophia deformans Paget. Unfallchirurgie 1997;23:18–22.
Deyrup AT, Montag AG, Inwards CY, Xu Z, Swee RG, Krishnan Unni K. Sarcomas arising in Paget disease of bone: a clinicopathologic analysis of 70 cases. Arch Pathol Lab Med 2007;131:942–946.
Sharma H, Mehdi SA, MacDuff E, Reece AT, Jane MJ, Reid R. Paget sarcoma of the spine: Scottish Bone Tumor Registry experience. Spine 2006;31:1344–1350.
Smith J, Botet JF, Yeh SD. Bone sarcomas in Paget disease: a study of 85 patients. Radiology 1984;152:583–590.
Cooper C, Harvey NC, Dennison EM, van Staa TP. Update on the epidemiology of Paget’s disease of bone. J Bone Miner Res 2006;21:P3–8.
Saraux A, Brun-Strang C, Mimaud V, Vigneron AM, Lafuma A. Epidemiology, impact, management, and cost of Paget’s disease of bone in France. Joint Bone Spine 2007;74:90–95.
Ringe JD, Kuhlencordt F. [Paget’s osteodystrophia deformans. Occurrence, clinical aspects and complications]. Dtsch Med Wochenschr 1979;104:1837–1842.
Schmorl G. Osteitis deformans Paget. Virchows Arch 1932;283:694.
van Staa TP, Selby P, Leufkens HG, Lyles K, Sprafka JM, Cooper C. Incidence and natural history of Paget’s disease of bone in England and Wales. J Bone Miner Res 2002;17:465–471.
Cooper C, Schafheutle K, Dennison E, Kellingray S, Guyer P, Barker D. The epidemiology of Paget’s disease in Britain: is the prevalence decreasing? J Bone Miner Res 1999;14:192–197.
Gardner MJ, Barker DJ. Mortality from malignant tumours of bone and Paget’s disease in the United States and in England and Wales. Int J Epidemiol 1978;7:121–30.
(DVO) AoG-LSOS. Leitlinien zur Diagnostik und Behandlung des Morbus PAget des Knochen. Available at: http://www.dvosteologie.de2006.
Kanis JA, Gray RE. Long-term follow-up observations on treatment in Paget’s disease of bone. Clin Orthop Relat Res 1987;217:99–125.
Siris ES. A potent new bisphosphonate for Paget’s disease of bone. Am J Med 1996;101:339–340.
Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, Mesenbrink P, Su G, Pak J, Zelenakas K, Luchi M, Richardson P, Hosking D. Comparison of a single infusion of zoledronic acid with risedronate for Paget’s disease. N Engl J Med 2005;353:898–908.
Joshua F, Epstein M, Major G. Bisphosphonate resistance in Paget’s disease of bone. Arthritis Rheum 2003;48:2321–2323.
Parvizi J, Klein GR, Sim FH. Surgical management of Paget’s disease of bone. J Bone Miner Res 2006;21:P75–82.
Kaplan FS. Severe orthopaedic complications of Paget’s disease. Bone 1999;24:43S–46S.
Ferguson DJ, Itonaga I, Maki M, McNally E, Gundle R, Athanasou NA. Heterotopic bone formation following hip arthroplasty in Paget’s disease. Bone 2004;34:1078–83.
Parvizi J, Schall DM, Lewallen DG, Sim FH. Outcome of uncemented hip arthroplasty components in patients with Paget’s disease. Clin Orthop Relat Res 2002:127–34.
Lusty PJ, Walter WL, Walter WK, Zicat B. Cementless hip arthroplasty in Paget’s disease at medium-term follow-up (average of 6.7 years). J Arthroplasty 2007;22:692–696.
Lee GC, Sanchez-Sotelo J, Berry DJ. Total knee arthroplasty in patients with Paget’s disease of bone at the knee. J Arthroplasty 2005;20:689–693.
Bidner S, Finnegan M. Femoral fractures in Paget’s disease. J Orthop Trauma 1989;3:317–322.
Author information
Authors and Affiliations
Corresponding author
Additional information
S. Seitz and M. Priemel have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Seitz, S., Priemel, M., von Domarus, C. et al. The Second Most Common Bone Disease: A Review on Paget’s Disease of Bone. Eur J Trauma Emerg Surg 34, 549–553 (2008). https://doi.org/10.1007/s00068-008-8208-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00068-008-8208-4